Lundbeck
HLUN-B.CO
#2505
Rank
S$7.79 B
Marketcap
$8.14
Share price
-0.93%
Change (1 day)
18.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : S$0.79 Billion

According to Lundbeck 's latest financial reports the company's total debt is S$0.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$0.81 B-24.62%
2022-12-31S$1.07 B-1.67%
2021-12-31S$1.09 B-36.51%
2020-12-31S$1.72 B-10.88%
2019-12-31S$1.93 B
2018-12-31N/A-100%
2017-12-31S$12.29 M-96.84%
2016-12-31S$0.38 B-50.28%
2015-12-31S$0.78 B8.32%
2014-12-31S$0.72 B42.39%
2013-12-31S$0.50 B22.4%
2012-12-31S$0.41 B-4.44%
2011-12-31S$0.43 B-2.37%
2010-12-31S$0.44 B-52.79%
2009-12-31S$0.93 B83.8%
2008-12-31S$0.51 B-2.58%
2007-12-31S$0.52 B34.72%
2006-12-31S$0.38 B284.95%
2005-12-31S$0.10 B-16.94%
2004-12-31S$0.12 B